CordenPharma is proactively responding to the evolving healthcare landscape by enhancing its capabilities in assembling auto-injectors and other complex drug delivery formats for chronic disease management. As the global pharmaceutical market shifts towards self-administered therapies, the demand
The shift from digital molecular design to physical realization is becoming increasingly accessible as automated lab hardware follows the rapid growth of AI software. This convergence has allowed independent researchers to bypass the gatekeepers of traditional pharmaceutical institutions,
Personalized medicine is emerging as a primary catalyst for manufacturing innovation, requiring flexible platforms that can efficiently produce high-yield therapies for smaller patient populations. This fundamental shift marks the end of the traditional era where massive, stainless-steel vats
Data filtering initiatives, such as excluding eukaryotic viruses from training sets, represent the first steps in preventing AI models from learning how to design human pathogens. This protective measure is increasingly vital as the intersection of artificial intelligence and the life sciences
The pursuit of engineering non-standard proteins has reached a significant milestone with the development of a system that reassigns sense codons on a massive scale. At the Wyss Institute for Biologically Inspired Engineering, a research group led by George Church has unveiled AGENTEX, a platform
The transition to automated systems is less about replacing scientific staff and more about liberating them from the mechanical motions of repetitive bench work. For decades, researchers spent significant portions of their day manually pipetting microvolumes of liquids into 96-well plates, a
